152 related articles for article (PubMed ID: 7295882)
21. Metabolic fact of 14C-isosorbide 5-mononitrate in humans.
Wood SG; John BA; Chasseaud LF; Major RM; Forrest ME; Bonn R; Darragh A; Lambe RF
Arzneimittelforschung; 1984; 34(9):1031-5. PubMed ID: 6542370
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of isosorbide dinitrate after cutaneous and sublingual doses to human subjects.
Mansel-Jones D; Taylor T; Doyle E; Chasseaud LF; Darragh A; O'Kelly DA; Over H
J Clin Pharmacol; 1978; 18(11-12):544-8. PubMed ID: 721951
[TBL] [Abstract][Full Text] [Related]
26. Isosorbide 5-mononitrate pharmacokinetics.
Chasseaud LF
Cardiology; 1987; 74 Suppl 1():6-11. PubMed ID: 3300979
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacokinetics of nitrates.
Bogaert MG
Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.
Sundberg S; Lehtonen L
Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioavailability of isosorbide-5-mononitrate in humans.
Rameis H; Bacher S; Eichler HG; Horwatitsch H
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):678-80. PubMed ID: 4093207
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of isosorbide dinitrate in the isolated perfused rabbit lung.
Mayer PR; Lubawy WC; McNamara PJ; Kostenbauder HB
J Pharm Sci; 1983 Jul; 72(7):785-9. PubMed ID: 6886987
[TBL] [Abstract][Full Text] [Related]
33. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].
Muck B; Bonn R; Rietbrock N
Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720
[TBL] [Abstract][Full Text] [Related]
34. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
35. Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate.
Ochs HR; Neugebauer G; Greenblatt DJ; Labedzki L
Klin Wochenschr; 1986 Dec; 64(23):1213-6. PubMed ID: 2879959
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.
Abshagen U; Betzien G; Endele R; Kaufmann B
Eur J Clin Pharmacol; 1981; 20(4):269-75. PubMed ID: 7308280
[TBL] [Abstract][Full Text] [Related]
37. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
[TBL] [Abstract][Full Text] [Related]
38. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
39. Influence of systemically given placebo, trapidil and isosorbide dinitrate on norepinephrine-evoked hand vein constriction in healthy subjects.
Sziegoleit W; Dannenberg K; Konschak A; Lautenschläger C; Presek P
Arzneimittelforschung; 2007; 57(2):81-6. PubMed ID: 17396617
[TBL] [Abstract][Full Text] [Related]
40. Influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate.
Sata H; Inoue K; Nii T; Kuroda T
Biol Pharm Bull; 1997 Oct; 20(10):1111-5. PubMed ID: 9353575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
